Marjoria Russell, LPN,HHA | |
255 Savannah St Se, Apt E, Washington, DC 20032-5471 | |
(202) 910-6553 | |
Not Available |
Full Name | Marjoria Russell |
---|---|
Gender | Female |
Speciality | Home Health Aide |
Location | 255 Savannah St Se, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225408198 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | LPN1006794 (District Of Columbia) | Secondary |
374U00000X | Home Health Aide | HHA11422 (District Of Columbia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Marjoria Russell, LPN,HHA 255 Savannah St Se, Apt E, Washington, DC 20032-5471 Ph: () - | Marjoria Russell, LPN,HHA 255 Savannah St Se, Apt E, Washington, DC 20032-5471 Ph: (202) 910-6553 |
News Archive
SDIX, a leading supplier of rapid detection solutions to the $1 billion food pathogen testing market, today announced that its RapidChek® SELECT™ Salmonella Enteritidis (SE) test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.
A group of scientists, led by mathematicians, has taken on the challenge of building a common model of immune responses.
Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has been ranked as a top global contract development and manufacturing organization. PharmSource(R), a respected independent pharmaceutical research organization, recently published a study looking at the number of FDA new drug approvals (NDAs and BLAs) which were outsourced by sponsor companies and subsequently launched.
In other news, The Boston Globe reports on one of the perks enjoyed by doctors who use electronic health records, and Bloomberg details the British Medical Association's advice to members to avoid patients on Facebook.
Currently, no definitive standard of care exists for adolescent and young adults (AYA) with acute lymphoblastic leukemia (ALL). Recent research suggests that AYAs treated with pediatric treatment protocols have better outcomes than those treated with adult treatment protocols.
› Verified 7 days ago